Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNFα and IL18 but not CXCL12

Ítems similars

• Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration
  per: Verburg, R, et al.
  Publicat: (2005)
• Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
  per: Baranauskaite, Asta, et al.
  Publicat: (2011)
• Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate
  per: Gratacós, J, et al.
  Publicat: (2007)
• High-dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of synovial abnormalities
  per: van Oosterhout, M, et al.
  Publicat: (2005)
• High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities
  per: van Oosterhout, M, et al.
  Publicat: (2005)